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Abstract
Background: Advanced glycation endproducts (AGE) and advanced oxidation protein products (AOPP) arise as a result
of excessive glycation and oxidation processes of proteins in hyperglycemia and oxidative stress conditions respectively,
both in vivo and in vitro. In vivo these processes are especially intensified in patients with diabetes, and the adverse
effects of AGE and AOPP are particularly unfavorable for the pathogenesis and aggravate the biochemical disturbances
and clinical complications of diabetes. Total AGE and AOPP (T-AGE and T-AOPP) are heterogeneous groups of
compounds, and they can be divided into two main fractions: high- and low-molecular-weight, i.e. HMW-AGE and
HMW-AOPP as well as LMW-AGE and LMW-AOPP. Therefore it is important to find natural substances that will prevent
formation of total AGE and AOPP and their high- and low-molecular-weight fractions and thereby reduce their adverse
effects on tissues and organs.
Method: Selected natural substances and dietary supplements such as vitamin C, aminoguanidine, quercetin and green
tea as well as the multicompound formulations Padma Circosan and Padma 28 were tested in an in vitro model using
bovine serum albumin (BSA). Fluorescence of T-, HMW- and LMW-AGE and concentration of T-, HMW- and LMW-AOPP
were measured after incubation with these substances.
Results: In the examined concentrations quercetin showed the greatest degree of inhibition for T-AGE (60.5 %) as well
as for HMW-AGE (79.5 %), while in the case of LMW-AGE the greatest degree of glycation inhibition was shown by
Padma Circosan (74.9 %). T-AOPP and HMW-AOPP were best inhibited by vitamin C (87.3 and 89.1 % respectively). The
results obtained for LMW-AOPP are atypical, but the lowest concentration was observed in a sample with Padma 28.
Conclusion: The results show that all tested natural compounds have inhibitory activity towards the formation of total
and low- and high-molecular-weight forms of AGE and AOPP in vitro. That suggest a possible role in the prevention of
diabetic complications, especially the multiherbal compound Padma preparations, which are especially effective in
lowering the most dangerous, i.e. LMW fractions.
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Background
The process of nonenzymatic glycation in in vivo condi-
tions occurs in almost all tissues and organs of the body,
and physiologically is associated with aging. However, its
intensity is significantly increased in diabetes, which is
characterized by a state of chronic hyperglycemia. In
these patients oxidative stress is also very often in-
creased, leading to oxidative damage of macromolecules
and tissues [1, 2]. Nonenzymatic glycation and oxidation
concerns proteins, lipids and nucleic acids, which cause
a series of adverse changes in their structure and func-
tion. The multi-stage conversion, initiated by a glucose
connection to free amino groups of proteins, leading to
the creation of glycation products, is commonly known
as the Maillard reaction. The last stage of this reaction is
the irreversible formation of advanced glycation endpro-
ducts (AGE). The amount of these compounds reflects
the intensity of protein glycation and its severity.
Similarly, as a result of multi-stage transformations of pro-
teins induced by oxygen and chlorine free radicals, ad-
vanced oxidation protein products (AOPP) are formed.
The main sources of oxidative compounds are neutro-
phils, which are especially stimulated in hyperglycemic
conditions. AGE and AOPP are also known as endogen-
ous toxins, and especially AOPP were defined as uremic
toxins in patients with end stage renal disease [2–5]. Al-
though the exact structure and properties of AGE and
AOPP are still not well recognized in spite of having been
intensively studied, strong similarity of these compounds
is indicated. In particular, their participation in the patho-
genesis and development of vascular late diabetic compli-
cations, including micro- and macroangiopathies, is
emphasized, and their role in diabetic nephropathy is
especially underlined. They are often the cause of rapidly
deteriorating health of diabetic patients and can lead to sig-
nificant shortening of their lifespan. In addition, AGE and
AOPP enhance the mechanisms related to inflammation
that lead to the respiratory burst of phagocytic cells, which
secondarily intensifies their increased formation [1, 2, 6–8].
AGE are a heterogeneous group of compounds, defined
as total AGE (T-AGE), mostly characterized by a specific
fluorescence and specific properties. They occur in two
main forms: high-molecular-weight AGE (HMW-AGE,
protein aggregates and their fragments, size up to 650 kDa)
and low-molecular-weight AGE (LMW-AGE, molecular
weight lower than 12 kDa) fractions [3, 6, 9]. Similarly,
total AOPP (T-AOPP) comprise a large group of com-
pounds with not fully defined structure, which also occur
as high-molecular-weight AOPP (HMW-AOPP, molecular
weight of up to 600 kDa) and low-molecular-weight AOPP
(LMW-AOPP, lower than 12 kDa) [5, 10]. They are cur-
rently being intensively investigated because of their role in
tissue and organ injury. Excessive AGE and AOPP forma-
tion and accumulation is particularly implicated in kidney
dysfunction, and very high levels were found in patients
with uremia and end-stage renal diseases [10–13]. In our
previous studies involving patients with type 2 diabetes, we
revealed a significant relationship of both AGE and AOPP
with development of diabetic angiopathies [14]. Moreover,
some studies indicate that LMW-AGE and LMW-AOPP
are more toxic than HMW species [12, 13]. It is therefore
vitally important to find a substance that can inhibit both
total as well as high- and low-molecular-weight AGE and
AOPP formation [3]. Besides the endogenous formation,
AGE are also taken up externally with food, which aug-
ments the unfavorable effect on the organism [6, 15, 16].
Our previous studies on the in vitro model allowed us
to find few substances of natural origin, which showed a
great ability to inhibit unfavorable processes of glycation
and oxidation (more than 50 % braking efficiency of
each of these processes). These substances are included
in the supplements commonly used in drugs and medi-
cines available without a prescription and are frequently
bought and used by people particularly vulnerable to
oxidative stress and increased glycation. As a result of
our previous studies of the best inhibiting processes of
glycation and oxidation compounds we include vitamin
C, green tea, aminoguanidine, quercetin and prepara-
tions Padma 28 and Padma Circosan [17, 18]. Due to
the fact, that LMW fractions of AGE and AOPP are
thought to be even more dangerous than the HMW
fractions [14] the natural substances mentioned above
were analysed regarding there inhibiting effects specific-
ally on these two main forms of AGE and AOPP.
Methods
Test substances and materials
Bovine serum albumin (BSA) was used as a model protein
in a concentration of 40 mg/mL (corresponding to the
physiological albumin concentrations in human blood). The
glycation and oxidation processes were carried out using
glucose and chloramine T solution in PBS (500 mg/mL and
20 mM respectively) as activators. Solutions of selected
natural origin substances with known anti-oxidative and/
or antiglycative effects were used: aminoguanidine (A) and
quercetin (Q) in concentrations of 50 mM, vitamin C
(ascorbic acid, VC) and green tea (GT) in a concentration
of 10 mM, Padma Circosan (PC) and Padma 28 (P28) in a
concentration of 2.5 %. Padma Circosan and Padma 28
are multiherbal formulations from 21 and 22 powdered
herbal drugs respectively. They are identical except that
Padma 28 additionally contains aconite tuber (1 mg/
403 mg). The full composition has been published else-
where [19]. All concentrations were chosen based on the
literature and our own previous experiments (data not
shown). As a negative control C(−) native BSA solution
was used, while as a positive control C(+) BSA solution
was incubated with glucose for glycation or with
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chloramine T for oxidation processes. Each experiment
was performed three times in triplicate.
Used in the study vitamin C, quercetin and aminogua-
nidine were the purest available from Sigma Aldrich
(US) substances (based on our previous studies [17, 18]
we decided to use these natural origin substances).
Padma 28 and Padma Basic preparations were obtained
from the manufacturer (Padma Inc., CH), while green
tea was from a dietary supplement from the company
Aboca (IT) (the composition contains green tea leaves
and pure green tea extract; preparation was measured
on the epigallocatechin gallate concentration). All
other reagents used in the study were from Sigma
Aldrich (US).
Glycation
To measure AGE formation, samples were incubated for
6 weeks at 37 °C in darkness, and then dialyzed (48 h in
PBS, pH 7.4, with one change of dialysis solution). The
characteristic fluorescence of total AGE as well as its high-
and low-molecular-weight fractions – i.e. HMW-AGE and
LMW-AGE (after their separation according to the
method described by Munch et al. [20]) – was measured.
A Perkin Elmer spectrofluorometer was used and 370 and
440 nm were applied as excitation and emission wave-
length, respectively. The results were converted according
to the following formula: AGE [AFU] = (F ×D) × 1000/V,
where: F = value of the measured fluorescence, D = sample
dilution (500 times – T-AGE, 20 times – HMW-AGE and
LMW-AGE) and V = volume of used sample (20 μL – T-
AGE, 100 μL – HMW-AGE and LMW-AGE). The results
are presented in AFU (arbitrary fluorescence units) as the
mean of three measurements.
Oxidation
The concentrations of total AOPP as well as its high-
and low-molecular-weight fractions – i.e. HMW-AOPP
and LMW-AOPP – were measured according to the
method described by Vitko-Sarsat et al. [5]. Separation
of LMW- and HMW-AOPP was performed in similar
conditions as in the case of AGE separation [20]. To
measure AOPP formation the samples were incubated
for 60 min at 37 °C in darkness, and then dialyzed (48 h
in PBS, pH 7.4, with one change of dialysis solution).
The characteristic colour at 340 nm was measured in a
Stat Fax 2100 spectrophotometer. The standard curve
(made in chloramine T with concentration from 0 to
100 μM) was used to calculate the AOPP concentration
and expressed in μM converted according to the formula:
AOPP [μM] = 1 / B × A ×D × 1000, where A = absorbance
of measured sample, D = dilution (10×), B = slope of the
calibration curve (B = 0.0141). The results are presented
as the mean of three measurements.
Electrophoresis
To confirm the accuracy of the applied procedure of
AGE and AOPP formation and their proper separation
into high- and low-molecular-weight fractions of AGE
and AOPP, electrophoresis was performed according to
the method described by Laemmli et al. [21]. A poly-
acrylamide gel with Coomassie Brilliant Blue G-250 re-
agent staining was used.
Statistical analysis
Statistical analysis was performed using Statistica 12.5
PL. The average and standard deviation (SD) were calcu-
lated. Next, we performed an analysis of the results for
examined samples and a negative control as compared
to a positive control using Student's t test. A P value less
than 0.05 was adopted as statistically significant.
Results
The levels of total AGE and total AOPP as well as their
HMW and LMW fractions in positive and negative
controls as well as in samples incubated with selected
natural substances are presented in Table 1. Bold font
indicates the lowest fluorescence/concentration of the
measured parameter, reflecting the strongest inhibitory
effect of the examined substances toward AGE and
AOPP formation in in vitro conditions. All tested sam-
ples and negative controls were statistically different
compared to C (+) (p <0.001).
For each tested compound the percentage inhibition of
glycation and oxidation processes compared to C(+) was
calculated (Figs. 1 and 2). In the case of LMW-AOPP, be-
cause of the obtained atypical results, the percentage
inhibition was compared to C(−). For each sample was SD
calculated and also marked on Figs. 1 and 2.
The effectiveness of the procedure of glycation and
oxidation of BSA was confirmed by the differences in
the concentration or fluorescence of all forms of AGE
and AOPP between positive and negative controls except
in the case of LMW-AOPP (where because of the atyp-
ical results the inhibition was calculated as % against the
C- value as 100 %). The largest difference was observed
for T-AOPP, where values obtained in the positive con-
trol were about 30.5 times higher compared to C(−).
Only in the case of LMW-AOPP were the obtained re-
sults atypical – the negative control was higher than in
the positive one. As shown in Table 1 and Figs. 1 and 2,
formation of T-AGE and T-AOPP was inhibited by all
examined substances – in the case of AGE to the extent
of more than 50 % and in the case of AOPP to the extent
of more than 60 % (except quercetin). The best inhibitory
effects of T-AGE and T-AOPP formation were achieved
by quercetin (60.5 %) and vitamin C (87.3 %) respectively.
In the case of the other examined substances T-AGE for-
mation was inhibited by 56.7, 55.9, 54.9, 52.6 and 52.3 %
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in samples incubated with vitamin C, Padma 28, amino-
guanidine, Padma Circosan and green tea respectively.
T-AOPP formation was inhibited by 69.3 and 68.5 % in
samples incubated with green tea and Padma Circosan, by
64.7 % with Padma 28, by 63.5 % with aminoguanidine,
and by 26.8 % in samples incubated with quercetin.
The formation of HMW fractions was also the most
inhibited by the same substances as T-AGE and T-
AOPP respectively. HMW-AGE formation was the most
strongly inhibited (the lowest HMW-AGE fluorescence)
by quercetin (79.5) and HMW-AOPP was best inhibited
by vitamin C (89.1 %). For all examined substances the
inhibitory effect on HMW-AGE formation was higher
than 50 %, and the HMW-AOPP formation inhibition
was higher than 60 % in all samples except quercetin.
HMW-AGE formation was 59.4 % inhibited by amino-
guanidine, 55.3 % by green tea, 54.3 % and 54.1 % by
Padma 28 and vitamin C respectively, and 50.9 % by
Padma Circosan. In the case of HMW-AOPP formation,
aminoguanidine inhibited the oxidation process by
78.7 %, Padma Circosan by 62.0 %, green tea by 58.0 %,
Padma 28 by 49.9 %, and quercetin only by 37.8 %.
The results obtained for the LMW-AGE revealed the
best inhibitory effect for samples incubated with Padma
Circosan. The level of LMW-AGE in these samples is
74.9 % lower than in C(+). The LMW-AGE formation
was inhibited by 72.7, 70.0, 67.9, 66.5 and by 65.8 % in
samples incubated with aminoguanidine, Padma 28,
green tea, vitamin C and quercetin, respectively. The
inhibition of LMW-AGE formation was higher than
65 % in all examined samples. In LMW-AOPP obtained
values differed by 50.0 to 65.4 % in examined substances
compared to the negative control. LMW-AOPP concen-
tration in the sample with Padma 28 was 65.4 % higher
Table 1 Results of fluorescence of AGE (T, HMW and LMW) and concentrations of AOPP (T, HMW)
T-AGE [AFUx104] HMW-AGE [AFUx103] LMW-AGE [AFUx103] T-AOPP [μMx103] HMW-AOPP [μM] LMW-AOPP [μM]
C(−) 3.6 3.0 1.1 5.0 87.4 36.9
C(+) 17.0 24.7 5.5 152.3 893.4 11.7
A 7.7 10.0 1.5 55.6 190.2 18.4
VC 7.4 11.4 1.8 19.4 97.7 n. a.
Q 6.7 5.1 1.9 111.5 555.3 16.3
GT 8.1 11.1 1.8 46.8 375.4 14.9
P28 7.5 11.3 1.6 53.7 447.3 12.8
PC 8.1 12.1 1.4 47.9 339.4 14.2
C(−) – negative control, C(+) – positive control, samples incubated with: A aminoguanidine, VC vitamin C, Q quercetin, GT green tea, P28 Padma 28, PC Padma Circosan















Fig. 1 Percentage inhibition of formation of all forms of AGE. Samples incubated with: A – aminoguanidine, VC – vitamin C, Q – quercetin, GT – green
tea, P28 – Padma 28, PC – Padma Circosan. SD values for each sample are marked on the corresponding bars
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than in the negative control, and results obtained for
remaining examined samples were 61.5, 59.6, 55.8 and
50.0 % higher in samples incubated with Padma Circosan,
green tea, quercetin and aminoguanidine respectively. The
LMW-AOPP formation was modified by more than
50.0 % in all examined samples. The result obtained for
vitamin C cannot be analyzed due to interference of the
test substance with reagents used for the isolation of
LMW-AOPP (interference was observed even in an
aqueous solution containing only vitamin C).
To check the effectiveness of the oxidation and glycation
process and of the separation of the HMW and LMW
fractions the samples were analyzed by gel electrophoresis.
HMW fractions of AGE and AOPP are present in molecu-
lar weights of 40 kDa or more (because of the large mass
of the aggregates, part of the protein did not enter the sep-
arating gel) in Figs. 3a and 4a. In Figs. 3b and 4b, a single
band 1of low-molecular-weight protein can be seen at the
end of the gel, corresponding to the size of 10 kDa or less.
The electrophoresis results confirm the correctness of the
separations of HMW and LMW fractions.
Discussion
Non-enzymatic glycation and oxidation of macromole-
cules, particularly proteins, are strongly associated with
hyperglycemia and oxidative stress conditions, which are
especially increased in diabetes. The results of these pro-
cesses are advanced glycation endproducts and advanced
oxidation protein products. Nonenzymatic modifications
alter the structure, function and properties of the pro-
teins. AGE and AOPP are more resistant to proteolysis
and are also more reactive, which leads to an increase in
the synthesis of free radicals, reactive oxygen, nitrogen
and chlorine species as well as protein radicals. At the
same time, these macromolecules are more susceptible
to subsequent oxidative modification themselves. This
leads to the creation of vicious circle of disturbances
that is particularly disadvantageous in patients with
diabetes due to the role of AGE and AOPP in the patho-
genesis and development of vascular late diabetic
complications [1, 6–8]. In vivo high-molecular-weight
fractions of these compounds are created by the crosslink
reactions and connections of these glycated or oxidized
proteins with other proteins and macromolecules (native
and modified). On the other hand, low-molecular-weight
fractions are mainly formed as a result of incomplete pro-
teolysis of total AGE or AOPP or as products of incom-
plete glycation (also called “free AGE”) or oxidation. They
also can be Maillard reaction products (early or middle
glycation products), and they constitute a low percentage
(10 % of all AGE) in the human blood. All fractions of
AGE and AOPP are regarded as toxic agents for the
organism, especially their low-molecular-weight fraction
[3, 22]. They may accumulate in tissues and organs and
activate RAGE receptors, which subsequently induce
intracellular signaling pathways and start an inflammatory
cascade. Thus AGE and AOPP may provoke chronic
inflammation, disturb organ function and cause e.g. dia-
betic nephropathy or retinopathy development, diabetic
atherosclerosis and cardiovascular disease [2, 5, 16, 23].
That is why it is so important to identify substances that
















Fig. 2 Percentage inhibition of formation of all forms of AOPP. Samples incubated with: A – aminoguanidine, VC – vitamin C, Q – quercetin,
GT – green tea, P28 – Padma 28, PC – Padma Circosan. SD values for each sample are marked on the corresponding bars. * Due to an atypically
lower value for C+ compared to C- the inhibition of LMW-AOPP was calculated as % against the C(−) value as 100 %
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especially in view of their nephrotoxicity. This is the goal
of recent intensive research efforts [2, 4, 9, 12]. We have
evaluated the inhibitory effects of selected natural com-
pounds, such as aminoguanidine, vitamin C, quercetin,
green tea and polyherbal formulations such as Padma
Circosan and Padma 28 on the formation of total AGE
and AOPP as well as on their HMW and LMW fractions.
The effectiveness of the experimental oxidation and glyca-
tion procedures was confirmed by the negative and posi-
tive controls. In the LMW-AOPP fraction the results for
the controls were atypical – the positive control resulted
in lower LMW-AOPP levels than the negative control.
This suggests that while spontaneous oxidation results in
increased formation of LMW-AOPP, in the experimental
conditions the oxidized proteins show a tendency to
aggregate rather than decay. Received by us results were
repeatable in each of the independently performed series
of experiments, so the authors decided to analyze and
present the results in the manuscript. Therefore in the
case of LMW-AOPP the results of the tested substances
were compared to the negative control and not to the
positive control.
The efficacy of the separation method of the HMW
and LMW fractions of both AGE and AOPP was
Fig. 3 Check of effectiveness of the separation of HMW and LMW AGE: electrophoresis a HMW-AGE, b LMW-AGE. MM – mass marker, buffer – PBS,
C - - negative control, C + −positive control, A –aminoguanidine, VC – vitamin C, Q – quercetin, GT – green tea, P28 – Padma 28, PC – Padma Circosan
Fig. 4 Check of effectiveness of the separation of HMW and LMW AOPP: electrophoresis a HMW-AOPP, b LMW-AOPP. MM – mass marker,
buffer – PBS, C - - negative control, C + −positive control, A –aminoguanidine, VC – vitamin C, Q – quercetin, GT – green tea, P28 – Padma 28,
PC – Padma Circosan
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confirmed by electrophoresis – in the HMW fractions
there are no proteins smaller than 40 kDa, and in the
LMW fractions there are no proteins larger than
10 kDa. The electrophoretic images were comparable to
the ones obtained by Vitko-Sarsat et al. [5].
Among the tested substances only aminoguanidine has
well-known glycation-inhibiting properties. The other
substances are known more for their antioxidant proper-
ties (e.g. vitamin C, green tea) [4, 24, 25]. The polyherbal
formulations Padma 28 and Padma Circosan have
known inhibitory effects on total AGE and total AOPP
formation, as we have shown previously [26]. The ability
to inhibit the total as well as the high- and low-
molecular-weight fractions of AGE and AOPP has to
our knowledge not yet been examined. The data
available in the scientific literature indicate a possible in-
hibitory effect only on the total AGE [4, 7], or AOPP
formation was investigated in general [2, 5, 17, 18, 26].
Currently there are no scientific studies that assess the
ability of the compounds examined by us to inhibit or
lower the HMW and LMW fractions of AGE and AOPP.
In our previous investigations [17] we observed a strong
inhibitory effect of both Padma preparations on forma-
tion of total AGE and AOPP in in vitro conditions, but
there is no information about their effects on the high-
and low-molecular-weight fractions of AGE and AOPP.
The present study revealed that all of the tested sub-
stances show the effects on glycative and oxidative
modification of proteins – in the experimental condi-
tions they reduced the levels of all examined com-
pounds. In the LMW-AOPP fractions all samples
showed higher values than the positive control, and be-
cause of these atypical results the reduced LMW-AOPP
levels were compared to the negative control.
The inhibitory effect of aminoguanidine on glycation
is well described in the scientific literature and depends
on the concentration of reagents, the incubation time,
the temperature and the type of the glycation agent. In
in vitro studies aminoguanidine inhibited the glycation
process to a high degree. In some experiments amino-
guanidine in a concentration of 10 mM inhibited the
T-AGE formation by 75.4 and 64.8 % after 15 and 30 days
of incubation respectively [27] or by 75 % in a concentra-
tion of 10 mM [28]. Hou et al. [29] observed almost
complete inhibition of the glycation by aminoguanidine in
a concentration of 100 mM. Furthermore, Gutierrez [30]
demonstrated the ability of aminoguanidine to inhibit the
glycation process by 58.3 % in in vitro conditions and con-
firmed this result in an in vivo study involving rats. Other
researchers also demonstrated an antioxidative effect of
aminoguanidine in rat models. These studies have shown
its ability to lower the activity of nitric oxide and glutathi-
one, and to lower the concentration of carbonyl groups,
leading to reduced glycation [31, 32]. To our knowledge,
up to now there has been no research on the effect of ami-
noguanidine on the formation of AOPP. Our experiments
show that aminoguanidine, in a concentration of 50 mM,
has a strong inhibitory effect (54.9 %) on the formation of
T-AGE as well as on T-AOPP formation (63.5 %). Amino-
guanidine also strongly inhibited formation of the HMW
and LMW fractions of AGE and of HMW-AOPP and
LMW-AOPP by 50–79 %.
As mentioned above, vitamin C is a substance with
well-known antioxidant properties. Jing et al. [33] ob-
served an antioxidant effect of vitamin C in a concentra-
tion of 0.3 mg/mL and inhibition of synthetic DPPH by
86 %. Also, Shah et al. [34] found that vitamin C has the
ability to scavenge free radicals and lower their concen-
tration by 84.6–98 % dose-dependently at concentrations
from 20 to 100 μg/mL. Furthermore, Zhang et al. [35]
reported that vitamin C in concentrations ranging from
6.25 to 200 mg/mL inhibits synthetic DPPH radicals and
ABTS dose-dependently by 45–85 % and 49–95 % re-
spectively. However, to our knowledge there are no
studies on the action of vitamin C on AOPP formation
or on the glycation process in in vivo studies. Tarwadi
and Agte [36] demonstrated an inhibitory effect on gly-
cation by about 20 %. The authors suggest that the effect
of vitamin C involves reduction of oxidative stress,
which may lead to a reduction of the escalating mecha-
nisms between oxidation and glycation. Similarly, Lavelli
et al. [37] also supported the ability of vitamin C to in-
hibit glycation, but stressed that its action still needs to
be confirmed. In contrast, Vinson and Howard [7] dem-
onstrated that vitamin C at a concentration of 20 mM
inhibits the process of glycation and AGE formation by
about 73 %. Our data confirm a strong inhibitory effect
of vitamin C in a concentration of 10 mM not only on
the oxidation but also on the glycation process, lowering
T-AOPP and T-AGE formation by 87.3 and 56.7 % re-
spectively. Vitamin C also showed strong inhibition of
HMW- and LMW-AGE and of HMW-AOPP formation
(54.1 to 89.1 % inhibition), and in the case of T-AOPP
and HMW-AOPP it even showed the best inhibitory
effect of all examined substances.
Quercetin, like vitamin C, is known as an antioxidant
and, as some authors suggest, has a comparable antioxi-
dative capacity. In concentrations of 6.25 to 200 mg/mL
it inhibited synthetic DPPH dose-dependently by 50–
95 % [35]. High antioxidant abilities of quercetin were
also confirmed at lower concentrations ranging from 20
to 100 μg/mL, its inhibition of synthesis of DPPH radi-
cals ranging from 95 to 98 % [34]. Inhibitory action of
this radical comparable to that of vitamin C was demon-
strated by Djouossi et al. [38]. However, to our know-
ledge, there have been no studies on the effect of
quercetin on AOPP formation. Some researchers have
reported an ability of quercetin to inhibit the glycation
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process in concentrations ranging from 50 to 200 μg/mL
[39] and to inhibit AGE formation by 76–99 %, whereas
other researchers demonstrated, at a concentration of
100 μg/mL, a capacity for glycation inhibition of only
around 33 % [40]. In our experiment, quercetin showed
the strongest inhibitory action on total AGE formation
by 60.5 % in a concentration of 50 mM. However, the in-
hibitory effect on T-AOPP formation was the weakest of
the examined substances, at 26.8 %. HMW and LMW
fractions of AGE and HMW-AOPP and LMW-AOPP
were inhibited by quercetin to a degree of 37.8 to
79.5 %, and it showed the strongest inhibitory effect on
HMW-AGE formation.
Green tea is often described as a highly antioxidant bev-
erage, and its oxidation inhibiting action has been studied
in different in vitro models and is well documented. For-
ester and Lambert [41] observed inhibition of DPPH rad-
ical synthesis by green tea extract by 88–92 %, regardless
of the used extraction medium (water, ethanol, ether).
Other authors measured the FRAP level in different types
of tea (green, black, oolong), and suggested that green tea
has the greatest antioxidant potential (one cup has an an-
tioxidative potential equivalent to 100–200 mg of vitamin
C) [42]. In in vivo studies green tea extract was shown to
have a high ability to inhibit the formation of AOPP (by
90 %). These studies also showed its inhibitory effect on
the glycation process, though the authors indicate the
need for further studies [43, 44]. However, other re-
searchers observed that green tea extract has no signifi-
cant effect on the process of glycation [45], whereas Babu
et al. [46] noted a decrease in fluorescence of AGE by
50 % in a rat model as well as antioxidant activity and an
ability to chelate divalent metal ions. To our knowledge,
there have been no scientific studies evaluating in vitro
the inhibitory action of green tea on the formation of
high- and low-molecular-weight fractions of AGE and
AOPP. Our data show its ability to inhibit T-AGE and T-
AOPP formation in a concentration of 10 mM by 52.3 and
69.3 % respectively. In our research inhibition of HMW-
and LMW-AGE and HMW-AOPP and LMW-AOPP for-
mation by green tea was between 55.3 and 67.9 %.
Padma 28 and Padma Circosan are herbal multicom-
pound medicines and exhibit a broad spectrum of actions,
e.g. a protective effect on blood vessels (both in micro-
and macrovascular areas), efficacy in peripheral athero-
sclerosis, and immunostimulatory and anti-inflammatory
mechanisms of action. Padma formulations have also been
shown to be able to scavenge free radicals and reduce the
oxidation of lipids [17, 19, 26, 47]. In our earlier study [17]
we demonstrated their strong ability to inhibit T-AGE and
T-AOPP formation (by 56 and 66 %, respectively, for oxi-
dation and glycation). Both Padma preparations in this
study also show strong inhibitory action towards T-AGE
and T-AOPP formation (55.9 and 64.7 % respectively for
Padma 28 and 52.6 and 68.5 % for Padma Circosan). They
also had a high inhibitory effect on HMW- and LMW-
AGE and HMW-AOPP formation within the range of
49.9 to 74.9 %. In the case of LMW-AOPP they exhibited
the strongest action – they show 65.4 and 61.5 % inhib-
ition respectively. Low concentrations of the LMW frac-
tions of AGE and AOPP are highly desirable because they
are especially noxious for the human organs and are par-
ticularly nephrotoxic. Although the exact mechanism of
action LMW is not fully known, some studies have found
increased LMW-AOPP levels in patients with kidney dis-
ease and also increased occurrence in patients with dia-
betes. LMW-AOPP are therefore suspected to contribute
to secondary diabetic micro- and macrovascular damage,
especially of the kidneys [3, 22].
Conclusions
The presented data show that all of the tested natural
substances decreased the level of oxidation and glycation
processes, which is reflected by lowering on T-AGE and
T-AOPP formation and also HMW and LMW fractions
formation in different degrees. In view of their role in
the pathogenesis of diabetic complications and the
medical and socioeconomic importance of these dis-
eases, it is vitally important to find compounds to inhibit
formation of the deleterious AGE and AOPP com-
pounds and especially of their LMW fractions. Our
results suggest a possible role of natural substances in
the treatment and prevention of diabetic vascular late
complications, whereby the two herbal multicompound
preparations Padma 28 and Padma Circosan influence
the formation of the especially dangerous LMW frac-
tions of AGE and AOPP the most. Nevertheless, the
scientific data concerning inhibition of HMW- and
LMW-AGE and AOPP are very limited, and more stud-
ies are needed, including in an in vivo setting. The ob-
tained results are promising, and due to the significant
adverse effects of AGE and AOPP in diabetes, the re-
search will be continued in cell lines or animals.
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